Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genomic and Proteomic Analysis of Docetaxel and Capecitabine in Breast Cancer
NCT00198237Phase 2Completed
- Sponsor
- Indiana University School of Medicine
- Start
- Mar 2003
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, capecitabine in breast cancer, sponsored by Indiana University School of Medicine. Started Mar 2003; status: completed.
02
Drugs
docetaxelcapecitabine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00198237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00198237.